Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $111,707 | 33 | 82.9% |
| Food and Beverage | $9,352 | 173 | 6.9% |
| Travel and Lodging | $7,255 | 24 | 5.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,560 | 4 | 2.6% |
| Acquisitions | $1,663 | 1 | 1.2% |
| Current or prospective ownership or investment interest | $1,130 | 5 | 0.8% |
| Entertainment | $124.18 | 2 | 0.1% |
| Unspecified | $0 | 7 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $100,782 | 106 | $0 (2024) |
| Alcon Research LLC | $19,450 | 9 | $0 (2024) |
| Vital Art and Science, LLC | $7,950 | 1 | $0 (2017) |
| US Retina LLC | $2,792 | 13 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $962.64 | 36 | $0 (2024) |
| Genentech USA, Inc. | $575.80 | 25 | $0 (2024) |
| NotalVision | $367.56 | 4 | $0 (2019) |
| Allergan, Inc. | $272.99 | 9 | $0 (2021) |
| Alcon Laboratories Inc | $268.94 | 2 | $0 (2018) |
| Alimera Sciences, Inc. | $251.39 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,526 | 31 | Alcon Research LLC ($3,000) |
| 2023 | $32,878 | 47 | Alcon Vision LLC ($27,564) |
| 2022 | $17,620 | 37 | Alcon Vision LLC ($16,791) |
| 2021 | $20,423 | 43 | Alcon Vision LLC ($11,698) |
| 2020 | $23,017 | 25 | Alcon Vision LLC ($18,964) |
| 2019 | $26,396 | 39 | Alcon Vision LLC ($23,651) |
| 2018 | $512.67 | 13 | NotalVision ($223.59) |
| 2017 | $8,420 | 14 | Vital Art and Science, LLC ($7,950) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/05/2024 | Alcon Research LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Ophthalmology | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/24/2024 | Alcon Research LLC | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | Alcon Vision LLC | Constellation (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Ophthalmology | ||||||
| 09/12/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/28/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: Ophthalmology | ||||||
| 08/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/29/2024 | Alcon Vision LLC | Luxor (Device), NGENUITY | Food and Beverage | In-kind items and services | $132.13 | General |
| Category: Ophthalmology | ||||||
| 06/28/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Ophthalmology | ||||||
| 06/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/14/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 05/10/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $99.64 | General |
| Category: Ophthalmology | ||||||
| 05/10/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $87.45 | General |
| Category: Ophthalmology | ||||||
| 05/10/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $76.88 | General |
| Category: Ophthalmology | ||||||
| 05/09/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $148.30 | General |
| Category: Ophthalmology | ||||||
| 05/09/2024 | Alcon Vision LLC | NGENUITY (Device) | Food and Beverage | In-kind items and services | $79.71 | General |
| Category: Ophthalmology | ||||||
| 05/08/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $107.80 | General |
| Category: Ophthalmology | ||||||
| 05/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $39.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/19/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: Ophthalmology | ||||||
| 04/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/15/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 4,912 | 40,662 | $11.8M | $4.2M |
| 2022 | 24 | 5,740 | 20,423 | $9.6M | $4.1M |
| 2021 | 22 | 5,293 | 15,877 | $8.1M | $3.6M |
| 2020 | 23 | 5,637 | 15,377 | $8.1M | $3.6M |
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 395 | 3,914 | $6.4M | $2.6M | 41.0% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 92 | 26,761 | $2.1M | $769,304 | 36.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 546 | 2,395 | $1.1M | $235,178 | 20.9% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 50 | 928 | $929,400 | $201,874 | 21.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 802 | 947 | $217,514 | $86,601 | 39.8% |
| 92134 | Imaging of retina | Office | 2023 | 875 | 2,535 | $193,970 | $77,200 | 39.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 40 | 396 | $242,720 | $70,274 | 29.0% |
| 92250 | Photography of the retina | Office | 2023 | 1,119 | 1,333 | $167,958 | $36,400 | 21.7% |
| J3490 | Unclassified drugs | Office | 2023 | 27 | 58 | $113,670 | $35,148 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 311 | 439 | $64,471 | $29,190 | 45.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 277 | 277 | $76,528 | $28,185 | 36.8% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 12 | 14 | $64,800 | $12,459 | 19.2% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 56 | 159 | $49,800 | $9,634 | 19.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $14,669 | $6,189 | 42.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 64 | 68 | $11,721 | $4,439 | 37.9% |
| J9999 | Not otherwise classified, antineoplastic drugs | Office | 2023 | 13 | 25 | $8,500 | $1,666 | 19.6% |
| 67515 | Injection of drug or substance into membrane covering eyeball | Office | 2023 | 29 | 44 | $7,488 | $1,318 | 17.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 27 | 28 | $6,132 | $978.93 | 16.0% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 73 | 77 | $6,160 | $867.32 | 14.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,529 | $688.25 | 45.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,516 | $673.65 | 44.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 29 | 189 | $755.00 | $150.10 | 19.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 389 | 4,062 | $5.9M | $2.9M | 48.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 86 | 1,780 | $1.1M | $393,267 | 36.2% |
| 67028 | Injection of drug into eye | Office | 2022 | 541 | 2,367 | $863,400 | $234,500 | 27.2% |
About Dr. Samuel Houston, MD
Dr. Samuel Houston, MD is a Retina Specialist healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2009. The National Provider Identifier (NPI) number assigned to this provider is 1851533236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Houston, MD has received a total of $134,791 in payments from pharmaceutical and medical device companies, with $5,526 received in 2024. These payments were reported across 249 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($111,707).
As a Medicare-enrolled provider, Houston has provided services to 21,582 Medicare beneficiaries, totaling 92,339 services with total Medicare billing of $15.6M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Orlando, FL
- Active Since 03/31/2009
- Last Updated 04/20/2023
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1851533236
Products in Payments
- Constellation (Device) $61,051
- NGENUITY (Device) $28,773
- mVT(R) Service (Device) $7,950
- ARGOS (Device) $5,600
- Centurion (Device) $2,100
- EYLEA (Biological) $819.38
- Viscoat (Device) $700.00
- Luxor (Device) $640.11
- FINESSE SHARKSKIN (Device) $463.52
- Lucentis (Biological) $412.02
- ForeseeHome (Device) $367.56
- OZURDEX (Drug) $278.83
- EYLEA HD (Biological) $219.22
- ILUVIEN (Drug) $141.35
- BEOVU (Drug) $128.93
- Vabysmo (Drug) $114.68
- STELLARIS PC (Device) $99.15
- P200DTx (Device) $71.51
- YUTIQ (Drug) $66.42
- Iluvien (Drug) $65.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Retina Specialist Doctors in Orlando
Matthew Cunningham, Md, MD
Retina Specialist — Payments: $356,361
John Lehr, Md, MD
Retina Specialist — Payments: $63,657
Jaya Kumar, Md, MD
Retina Specialist — Payments: $22,212
Elia Mavrofrides, Md, MD
Retina Specialist — Payments: $13,251
Gabrielle Turski, Md Phd, MD PHD
Retina Specialist — Payments: $4,476
Dr. John Randolph, Md, MD
Retina Specialist — Payments: $2,902